Obese

Metabolic·MeSH: Obesity

5 drugs in development·5 companies·6 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
ursodiol	Optec International, Inc. (GM)

Phase 2(2)

Drug	Company
aleniglipron	Structure Therapeutics Inc. (GPCR)
ALN-4324	ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Phase 1(2)

Drug	Company
CRB-913	Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CRB-913	Crinetics Pharmaceuticals, Inc. (CRNX)

BioSniper tracks 5 drugs in development for Obese across 5 companies.

There are 6 clinical trials targeting Obese tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.